Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
Deslouches B, Di YP. · 2017
Read Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. by Deslouches B, Di YP. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5542299.txt.
Description
Deslouches and Di review antimicrobial peptides as possible cancer drugs in Oncotarget. Cancer drugs often fail two ways. Tumors learn to resist them, and they poison healthy fast-growing cells. Peptides that kill bacteria may dodge both flaws.
These peptides carry a positive charge and a split water-loving, water-hating shape. They stick to negatively charged cell surfaces. Bacterial surfaces carry such charges in plenty. Cancer cells expose more of one charged lipid than normal cells do. That gap could let the peptides hit tumors while sparing healthy tissue. Since binding needs no exact receptor, resistance may be slow to arise. The review centers on how these peptides kill. Readers get the case for a cheap, selective drug class.
Catalog record
| CREATOR | Deslouches B, Di YP. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |